Menu
A company that specialises in the supply of various medical equipment such as MRI scanners, CT scanners, ultrasound machines, dialysis consumables is looking for suppliers of Various Finished Formulations:
1. Aflibercept 100 mg/4 ml (5 Units) & 200 mg/8 ml (5 Units) Vials
2. Bevacizumab 100 mg/4 ml (15 Units) & 400 mg/16 ml (15 Units) Vials
3. Bimatoprost 0.01% (1,000 Units), 0.3 mg/mL (1,000 Units) Ophthalmic Solution
4. Bimatoprost 0.3 mg/ml + Timolol 5 mg/ml (400 Units) Ophthalmic Solution
5. Brimonidine 0.15% w/v (1,000 Units) Ophthalmic Solution
6. Brimonidine 2 mg + Brinzolamide 10 mg (1000 Units) Ophthalmic Solution
7. Brimonidine Tartrate 2 mg + Timolol maleate 5 mg (3000 Units) Ophthalmic solution
8. Brinzolamide 1% w/v (1,000 Units) Ophthalmic Solution
9. Brinzolamide 10 mg + Timolol maleate 5 mg (1000 Units) Ophthalmic solution
10. Cyclopentolate Hydrochloride 0.5% (200 Units) & 1% (200 Units) Ophthalmic Solution
11. Epinastine Hydrochloride 0.5 mg/ ml (2,000 Units) Ophthalmic Solution
12. Fluorometholone 0.1 % w/v + Neomycin 0.35 % w/v (232 Units) Ophthalmic solution
13. Latanoprost 50 mcg (400 Units) + Timolol Maleate 6.8 mg (400 Units) Ophthalmic Solution
14. Latanoprost 50 mcg (2000 Units) Ophthalmic Solution
15. Levobunolol 0.5% (1,000 Units) Ophthalmic Solution
16. Moxifloxacin Hydrochloride 5.45 mg/ml (2,000 Units) Ophthalmic Solution
17. Nepafenac 1 mg (1,000 Units) & 3 mg (1,000 Units) Ophthalmic Solution
18. Ofloxacin 0.3% w/v (81 Units) Ophthalmic Solution
19. Olopatadine 1 mg/ml (2,000 Units) Ophthalmic Solution
20. Polyethylene Glycol 400 0.4% + Propylene Glycol 0.3% (1,000 Units) Ophthalmic Solution
21. Polyvinyl Alcohol 1.4% (5,000 Units) Ophthalmic Solution
22. Povidone 0.6% (5,000 Units) Ophthalmic Solution
23. Prednisolone Acetate (microfine suspension) 1% (1,000 Units) Ophthalmic Solution
24. Travoprost 40 mcg/ml + Timolol Maleate 5 mg/ml (400 Units) Ophthalmic Solution
25. Timolol 6.8 mg (400 Units) Ophthalmic Solution
26. Travoprost 0.004 % (2,000 Units) Ophthalmic Solution
15 Feb 2020

Reply

15 Feb 2020